Grouping Rules: Single Devices, Groups, Families and Group Families

1. Key takeaways

Nigeria recognizes 4 application units: the single medical device, the medical device group, the medical device family and the medical device group family. Which one you choose directly determines the number of applications, the fees, and the complexity of later changes.

The definitions of these 4 concepts all sit in the interpretation section of Regulation 51, and the boundaries are drawn quite strictly:

• Device family: devices manufactured by the same manufacturer that differ only in shape, colour, flavour and size, and share the same design, manufacturing process and intended use — note the word only;
• Device group: a procedure pack or tray sold under a single name;
• Device group family: a set of products under the same generic name that differ only in the quantity and combination of products.

2. Legal basis

3. Expert insights

Insight 1: the word only in the device family definition is the easiest trap.

Regulation 51 defines the device family as devices that differ only in shape, colour, flavour and size. This means: different materials, different sterilization methods or different performance specifications do not make one family, however similar the products look. Chinese companies often treat a product series as a family; in Nigeria it will be split into multiple applications. The cost of the mistake is not only extra fees but extra dossiers, extra certificates and extra renewal dates to track.

Insight 2: the core of the device group definition is a procedure pack or tray sold under a single name.

A device group is not a set of similar products; it is one procedure pack or tray, and it must be sold under a single name. Typical examples are surgical instrument kits, dressing kits and biopsy trays. The test is: it is a combination assembled once and sold under one name, not a product line. Products that are merely shipped together in one carton, or sold by a distributor as a set, do not qualify.

Insight 3: the device group family is the narrowest of the three concepts.

Regulation 51 defines the device group family as a set of products under the same generic name that differ only in the quantity and combination of products. Two limits are stacked: the generic name must be identical, and the only permitted differences are quantity and combination. In effect this is the channel designed for the same product in different pack sizes.

Insight 4: grouping strategy and change management are linked.

Regulation 6 requires that no change be implemented without prior notification or approval. If products with real differences are forced into one family, any change to one member will drag the whole family with it — one application saved now is repaid later in change-management complexity. The distribution ban under Regulation 6(4), discussed in article 32, applies equally when a family member changes, which can freeze sales of the entire unit at once.

Insight 5: a classification difference vetoes grouping outright.

If the risk classifications of a set of products differ (for example, class A versus class C according to the duration of invasiveness under rule 5 of the First Schedule), they cannot be placed in the same application unit — because classification determines the review pathway (whether a dossier screening clearance is needed, whether an FDRC meeting is required). Consistent classification is the precondition of grouping. Verify classification before any grouping proposal is put into the project plan, since it cannot be negotiated afterwards.

4. Practical recommendations

1. Classify first, then group — never merge products with inconsistent classification (Regulation 3 plus the First Schedule).
2. Screen families with the only-word standard: split whenever materials, sterilization or performance specifications differ.
3. Route procedure packs and trays through group, and different pack sizes through group family, keeping each in its place.
4. Assess change spillover: fees saved by merging may be repaid as change complexity.
5. State the chosen unit type and its basis in the application documents, so reviewers can locate the reasoning.
6. Handle IVD test kits separately; Regulation 51 defines them independently.

5. Verification checklist

• □ Classification determination completed, confirming that the products proposed for merging share the same class.
• □ Device family members differ only in shape, colour, flavour or size (Regulation 51).
• □ Device groups are procedure packs or trays sold under a single name.
• □ Device group families share the same generic name and differ only in quantity and combination.
• □ Change spillover risk has been assessed (Regulation 6).
• □ The application documents state the chosen unit type and its basis.
• □ Test kits are handled separately under Regulation 51.

Regulatory information verified as of 29 October 2026. All content cited in this document has been checked against the official NAFDAC regulation text (S.I. No. 42 of 2024, Regulations 3, 4(1)(a), 6 and 51) and the two guidelines (VBM-R&RA-GDL-001-01 §2.1–§2.2 and §3.1, effective 10 April 2025; VBM-R&RA-GDL-005-01, effective 17 March 2025); the definitions of the four application units all come from the interpretation in Regulation 51.

• Local Nigeria resources: GRZAN can coordinate locally licensed import entities and authorized representative resources, covering NAPAMS online submission, dossier screening clearance interfacing, import permits, sample delivery and laboratory analysis support.
• Service capability: classification determination, registration pathway selection, technical documentation (IMDRF ToC) drafting, CMFS and notarization/legalization, GMP and foreign inspection preparation, advertisement permits, vigilance and PMS reporting, change management and renewal.
• Contact: info@grzanglobal.com; website www.grzan.cn.